GB9516606D0 - Antibodies their preparation and use - Google Patents

Antibodies their preparation and use

Info

Publication number
GB9516606D0
GB9516606D0 GBGB9516606.2A GB9516606A GB9516606D0 GB 9516606 D0 GB9516606 D0 GB 9516606D0 GB 9516606 A GB9516606 A GB 9516606A GB 9516606 D0 GB9516606 D0 GB 9516606D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9516606.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOENHANCEMENTS Ltd
Original Assignee
BIOENHANCEMENTS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOENHANCEMENTS Ltd filed Critical BIOENHANCEMENTS Ltd
Priority to GBGB9516606.2A priority Critical patent/GB9516606D0/en
Publication of GB9516606D0 publication Critical patent/GB9516606D0/en
Priority to EP96912152A priority patent/EP0871673B1/en
Priority to AU55092/96A priority patent/AU5509296A/en
Priority to DE69636015T priority patent/DE69636015T2/en
Priority to PCT/GB1996/001066 priority patent/WO1996034892A1/en
Priority to JP53312896A priority patent/JP4212111B2/en
Priority to US10/829,404 priority patent/US20040197336A1/en
Pending legal-status Critical Current

Links

GBGB9516606.2A 1995-05-03 1995-08-04 Antibodies their preparation and use Pending GB9516606D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9516606.2A GB9516606D0 (en) 1995-08-04 1995-08-04 Antibodies their preparation and use
EP96912152A EP0871673B1 (en) 1995-05-03 1996-05-02 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety
AU55092/96A AU5509296A (en) 1995-05-03 1996-05-02 Bispecific antibodies in which the binding capability is rev ersibly inhibited by a photocleavable moiety
DE69636015T DE69636015T2 (en) 1995-05-03 1996-05-02 BIS-SPECIFIC ANTIBODIES IN WHICH THE BINDING ABILITY IS INHERITIZED BY A MEDIUM-SPLITABLE GROUP REVERSIBLE
PCT/GB1996/001066 WO1996034892A1 (en) 1995-05-03 1996-05-02 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety
JP53312896A JP4212111B2 (en) 1995-05-03 1996-05-02 Bispecific antibodies whose binding ability is reversibly inhibited by photocleavable molecules
US10/829,404 US20040197336A1 (en) 1995-05-03 2004-04-20 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9516606.2A GB9516606D0 (en) 1995-08-04 1995-08-04 Antibodies their preparation and use

Publications (1)

Publication Number Publication Date
GB9516606D0 true GB9516606D0 (en) 1995-10-11

Family

ID=10779198

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9516606.2A Pending GB9516606D0 (en) 1995-05-03 1995-08-04 Antibodies their preparation and use

Country Status (1)

Country Link
GB (1) GB9516606D0 (en)

Similar Documents

Publication Publication Date Title
IL118825A0 (en) 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use
IL119864A0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
GB2298422B (en) Compounds and their use
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
IL116325A0 (en) Substituted 1h-imidazoles their preparation and use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
IL126811A0 (en) Human b-cell antigens and related reagents
IL118237A0 (en) Polysiloxane-polyol macromers their preparation and their use
IL122216A0 (en) Dolastatin derivatives their preparation and use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
IL116710A0 (en) Substituted 2-phenylpyridines their preparation and use
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
IL118295A0 (en) 3-(2- trialkylsilyloxy) ethyl-7-ethyl-1H- indoles and their preparation
ZA96240B (en) Novel peptides their preparation and use
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
IL116658A0 (en) Peptides their preparation and use
IL116711A0 (en) Substituted 2-phenylpyridines their preparation and use
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
IL122686A0 (en) Benzylhydroxylamines their preparation and use
EP0744125A3 (en) Iodo-complex and its use
AU4459196A (en) Sustained-release preparation and use
IL118629A0 (en) N-Substituted cis-N-propenyl-acetemides their preparation and use
GB9516606D0 (en) Antibodies their preparation and use
GB9526407D0 (en) Substances and their uses